LEX-05

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLEX-05
Drug Alias NameAAV vector-delivered superoxide dismutase 3 (LEXEO Therapeutics)SOD3 gene therapy (LEXEO Therapeutics)LEX-05
ClassificationBiologics
Mechanisms of ActionSuperoxide dismutase 3 stimulants
TargetsSuperoxide dismutase 3
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLexeo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLexeo Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A